U.S. Vascular Grafts Market Share Analysis Report, 2024-2033
The U.S. vascular grafts market size was estimated at USD 692.30 million in 2023 and is projected to hit around USD 1,349.18 million by 2033, growing at a CAGR of 6.9% during the forecast period from 2024 to 2033.
Key Takeaways:
U.S. Vascular Grafts Market Growth
Key factors driving market growth include the increasing prevalence of cardiovascular diseases, diabetes, and end-stage renal disease. A rise in the number of people suffering from these conditions is expected to boost the demand vascular grafts in the coming years. Moreover, development of novel technologies, such as tissue-engineered materials, is expected to boost market revenue over the forecast period.
There is a high burden of CVDs in the region owing to the aging population and unhealthy lifestyle. Economic development and the presence of advanced research centers, hospitals, medical device manufacturers, & universities are among the key factors boosting development and commercialization of new products in this region. The presence of a supportive reimbursement framework and sophisticated health infrastructure is also expected to contribute to market growth.
CVDs are the leading cause of death in Americas. As per CDC estimates, per year nearly, 1% or about 40,000 births are affected by Congenital Heart Defects (CHDs) in the U.S. The most common type of heart defect across the world is ventricular septal defect. The growing prevalence of heart diseases in the region, advancements in technologies & procedural techniques, and growing preference for minimally invasive surgeries are some of the factors further propelling the market growth.
Ongoing research activities about the modification of ePTFE vascular grafts with O-carboxymethylchitosan, which enhances the hydrophilicity of ePTFE grafts, are expected to drive the demand for prosthetic grafts. Supportive reimbursement policies for vascular surgeries, increase in patient spending power, and a rise in the demand for advanced vascular grafts are anticipated to create lucrative growth opportunities over the forecast period.
U.S. Vascular Grafts Market Report Scope
| Report Attribute | Details |
| Market Size in 2024 | USD 740.07 million |
| Market Size by 2033 | USD 1,349.18 million |
| Growth Rate From 2024 to 2033 | CAGR of 6.9% |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | Product, Application, Raw Material |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Key Companies Profiled | Medtronic, Terumo Corporation, LeMaitre Vascular, Inc., Getinge AB, BD (Becton Dickinson), Abbott, B. Braun Melsungen AG., W. L. Gore and Associates, Inc., MicroPort Scientific Corporation, Endologix |
Segments Insights:
Application Insights
The cardiac aneurysm market led the vascular grafts market with a revenue share of 51.9% in 2023. This can be attributed to an increase in the prevalence of cardiovascular diseases and improvements in the development of advanced tissue-engineered grafts for pediatric congenital heart surgeries. Furthermore, the market is expected to grow during the forecast period due to key factors such as the development of novel prosthetic grafts with improved porosity & efficiency coupled with growing acceptance of these grafts. The increasing prevalence of unruptured saccular aneurysms, affecting the flow of intracranial arteries, is expected to boost the market for vascular grafts over the forecast period.
The vascular occlusion segment is expected to witness the highest growth over the forecast period. The increasing prevalence of vascular occlusive diseases and easy availability of graft procedures, especially the saphenous vein graft, are expected to drive the demand for vascular grafts during the forecast period. Technological advancements resulting in the development of novel therapies, such as warfarin, which help reduce the severity of acute ischemia after occlusion of PTFE grafts, are anticipated to minimize the risks associated with prosthetic vascular grafts. This, in turn, is expected to drive the adoption of vascular grafts during the forecast period.
Raw Materials Insights
The polytetrafluoroethylene (PTFE) vascular grafts segment led the vascular grafts market with a revenue share of 45.12% in 2023. Key factors responsible for the largest share include rising demand for novel engineered prosthetics and technologically advanced products. Furthermore, low risk of degradation and infection due to polytetrafluoroethylene grafts is a key factor contributing to the largest share of this segment. PTFE is made using a technologically sophisticated design that results in low blood loss and high delamination resistance, also used in extra anatomical procedures and peripheral bypasses. Hence, these vascular grafts are anticipated to gain more market share during the forecast period.
The polyester vascular grafts segment is expected to witness considerable growth over the forecast period. Easy availability of raw materials, high tensile strength, and durability are key factors that can be attributed to its market share. Furthermore, extensive use of Dacron durable polyester incorporated with mitogenic properties and an increasing number of clinical trials for the development of highly durable polyester grafts are expected to drive the market growth over the forecast period.
Product Insights
The endovascular stent grafts segment led the vascular grafts market with a revenue share of 64.27% in 2023. This can be attributed to the increasing number of abdominal aortic aneurysm procedures with less potential for access-site complications. Furthermore, the reduced mortality rate associated with this treatment and technological advancements in novel product development are among the factors expected to positively influence market growth during the forecast period. In addition, these stent-grafts, in combination with antibiotics, can be used as an alternative for the treatment of mycotic aneurysms. As open surgeries consume longer time and there is excessive blood loss associated with them, minimally invasive endovascular stent grafts are expected to gain momentum during the forecast period.
The peripheral vascular grafts segment is expected to witness considerable growth over the forecast period. The market for peripheral vascular grafts is mainly driven by a wide number of medical applications and improvements in the development of intraoperative techniques. The rising prevalence of Peripheral Artery Diseases (PADs) is one of the key factors that can be attributed to market growth. Technological advancements in the development of novel products for the treatment of PAD are anticipated to drive demand for peripheral vascular grafts during the forecast period.
Recent Developments
Key U.S. Vascular Grafts Company Insights
Medtronic, Terumo Corporation, BD, and Abbott are some of the prominent companies in U.S. vascular grafts market. These key players are identified based on their product portfolios, revenues, collaborations, and other strategic initiatives adopted by them.
The increasing use of vascular grafts in primary heart care is expected to boost the regional market. Key players are investing and expanding their businesses in the region, boosting regional market growth. This is attributed to several factors, such as increased adoption of such devices, rising technological advancements, and increased product launches by the key players operating in the market.
Key U.S. Vascular Grafts Companies:
Segments Covered in the Report
This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the U.S. Vascular Grafts market.
By Product
By Application
By Raw Material
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Raw material
1.2.4. Country scope
1.2.5. Estimates and forecast timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. nova one advisor’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.1.1. Approach 1: Commodity flow approach
1.7.2. Volume price analysis (Model 2)
1.7.2.1. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Application outlook
2.2.3. Raw material outlook
2.2.4. Country outlook
2.3. Competitive Insights
Chapter 3. Vascular Grafts Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing prevalence of cardiovascular diseases
3.2.1.2. Technological advancements in vascular surgery
3.2.1.3. Rising demand for vascular access for hemodialysis
3.2.2. Market restraint analysis
3.2.2.1. High cost of vascular graft procedures
3.2.2.2. Risk of complications and graft failure
3.3. Vascular Grafts Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Vascular Grafts Market: Product Estimates & Trend Analysis
4.1. Vascular Grafts Market: Product Dashboard
4.2. Vascular Grafts Market: Product Movement Analysis
4.3. Vascular Grafts Market Size & Forecasts and Trend Analysis, by Product, 2020 to 2033
4.4. Hemodialysis Access Grafts
4.4.1. Market estimates and forecasts 2020 to 2033
4.5. Endovascular Stent Grafts
4.5.1. Market estimates and forecasts 2020 to 2033
4.6. Coronary Artery By-Pass Grafts
4.6.1. Market estimates and forecasts 2020 to 2033
4.7. Vascular Grafts for Aorta Disease
4.7.1. Market estimates and forecasts 2020 to 2033
4.8. Peripheral Vascular Grafts
4.8.1. Market estimates and forecasts 2020 to 2033
Chapter 5. Vascular Grafts Market: Application Estimates & Trend Analysis
5.1. Vascular Grafts Market: Application Dashboard
5.2. Vascular Grafts Market: Application Movement Analysis Vascular Grafts Market Size & Forecasts and Trend Analysis, by Application, 2020 to 2033
5.3. Cardiac Aneurysm
5.3.1. Market estimates and forecasts 2020 to 2033
5.3.2. Endovascular Stent Graft
5.3.2.1. Market estimates and forecasts 2020 to 2033
5.3.3. Vascular Graft
5.3.3.1. Market estimates and forecasts 2020 to 2033
5.4. Kidney Failure
5.4.1. Market estimates and forecasts 2020 to 2033
5.5. Vascular Occlusion
5.5.1. Market estimates and forecasts 2020 to 2033
5.6. Coronary Artery Disease
5.6.1. Market estimates and forecasts 2020 to 2033
Chapter 6. Vascular Grafts Market: Raw Material Estimates & Trend Analysis
6.1. Vascular Grafts Market: Raw Material Dashboard
6.2. Vascular Grafts Market: Raw Material Movement Analysis
6.3. Vascular Grafts Market Size & Forecasts and Trend Analysis, by Raw Material, 2020 to 2033
6.4. Synthetic Vascular Grafts
6.4.1. Market estimates and forecasts 2020 to 2033
6.4.2. Polytetrafluoroethylene (PTFE) Grafts
6.4.2.1. Market estimates and forecasts 2020 to 2033
6.4.3. Polyester Grafts
6.4.3.1. Market estimates and forecasts 2020 to 2033
6.4.4. Polyurethane Grafts
6.4.4.1. Market estimates and forecasts 2020 to 2033
6.5. Biological Vascular Grafts
6.5.1. Market estimates and forecasts 2020 to 2033
6.5.2. Autografts
6.5.2.1. Market estimates and forecasts 2020 to 2033
6.5.3. Allografts
6.5.3.1. Market estimates and forecasts 2020 to 2033
6.5.4. Xenografts
6.5.4.1. Market estimates and forecasts 2020 to 2033
6.6. Hybrid Vascular Grafts
6.6.1. Market estimates and forecasts 2020 to 2033
Chapter 7. Competitive Landscape
7.1. Recent Developments & Impact Analysis, By Key Market Participants
7.2. Company/Competition Categorization
7.3. Vendor Landscape
7.3.1. List of key distributors and channel partners
7.3.2. Key customers
7.3.3. Key company market share analysis, 2023
7.3.4. Medtronic
7.3.4.1. Company overview
7.3.4.2. Financial performance
7.3.4.3. Modality benchmarking
7.3.4.4. Strategic initiatives
7.3.5. Terumo Corporation
7.3.5.1. Company overview
7.3.5.2. Financial performance
7.3.5.3. Modality benchmarking
7.3.5.4. Strategic initiatives
7.3.6. LeMaitre Vascular, Inc.
7.3.6.1. Company overview
7.3.6.2. Financial performance
7.3.6.3. Modality benchmarking
7.3.6.4. Strategic initiatives
7.3.7. B. Braun Melsungen AG
7.3.7.1. Company overview
7.3.7.2. Financial performance
7.3.7.3. Modality benchmarking
7.3.7.4. Strategic initiatives
7.3.8. Getinge AB
7.3.8.1. Company overview
7.3.8.2. Financial performance
7.3.8.3. Modality benchmarking
7.3.8.4. Strategic initiatives
7.3.9. BD (Becton Dickinson)
7.3.9.1. Company overview
7.3.9.2. Financial performance
7.3.9.3. Modality benchmarking
7.3.9.4. Strategic initiatives
7.3.10. W. L. Gore and Associates, Inc.
7.3.10.1. Company overview
7.3.10.2. Financial performance
7.3.10.3. Modality benchmarking
7.3.10.4. Strategic initiatives
7.3.11. Abbott
7.3.11.1. Company overview
7.3.11.2. Financial performance
7.3.11.3. Modality benchmarking
7.3.11.4. Strategic initiatives
7.3.12. MicroPort Scientific Corporation
7.3.12.1. Company overview
7.3.12.2. Financial performance
7.3.12.3. Modality benchmarking
7.3.12.4. Strategic initiatives
7.3.13. Endologix
7.3.13.1. Company overview
7.3.13.2. Financial performance
7.3.13.3. Modality benchmarking
7.3.13.4. Strategic initiatives
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers